A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.
Prostate-specific membrane androgen PET/CT can help clinicians intensify or de-escalate care for men with prostate cancer who ...
Scans that make prostate cancer cells glow can eliminate the need for invasive biopsies and cut false positive—and they're ...
An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following ...
Australian scientists say it could also help reduce the risk of overdiagnosis by determining which cancers are low-risk and ...
The second most common cancer among men is prostate cancer, affecting 1 in 8 men. Prostate cancer is treatable, in most cases, when the cancer remains localized to the prostate gland. But if the ...
AI-assisted imaging improved prostate cancer diagnosis and biopsy decision-making in new research presented at EAU 2026.
First Focal One ® procedure utilizing Cortechs.ai’s advanced MRI-imaging technology, OnQ Prostate, successfully performed at the University of California, San Francisco Prostate Cancer Center OnQ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results